Methylation of RAR-β2, RASSF1A, and CDKN2A genes induced by nickel subsulfide and nickel-carcinogenesis in rats

Biomedical and Environmental Sciences

Volumn 24, Issue 2, 2011, Pages 163-171

  Zhang, Jun ^a   Zhang, Jing ^b   Li, MengJie ^b   Wu, YouJun ^b   Fan, YingYing ^a   Zhou, Yang ^a   Tan, LiLi ^b   Shao, ZhiHua ^a   Shi, HongJun ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

CDKN2A; DNA methylation; Nickel; Quantitative Real time Methylation Specific PCR; RAR 2; RASSF1A

Indexed keywords

CARCINOGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; NICKEL; NICKEL SUBSULFIDE; RASSF1 PROTEIN, RAT; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR BETA; TUMOR SUPPRESSOR PROTEIN;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; CPG ISLAND; DNA METHYLATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; MALE; METABOLISM; MUSCLE TUMOR; RAT; WISTAR RAT;

ANIMALS; CARCINOGENS; CPG ISLANDS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; LUNG NEOPLASMS; MALE; MUSCLE NEOPLASMS; NICKEL; RATS; RATS, WISTAR; RECEPTORS, RETINOIC ACID; TUMOR SUPPRESSOR PROTEINS;

RATTUS; RATTUS NORVEGICUS;

EID: 79955920198     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: 10.3967/0895-3988.2011.02.011     Document Type: Article

References (32)

1. Costa M. Mechanisms of nickel genotoxicity and carcinogenicity. In: Chang LW, Magos L, Suzuki T (eds). Toxicology of Metals, vol 1. Lewis Publishers, New York, 1996; pp. 245-51.
2. Lu HT, Shi XL, Costa M, et al . Carcinogenic effect of nickel compounds Nelson Institute of Environmental Medicine. Molecular and Cellular Biochemistry, 2005; 279(1-2), 45-67.
3. Denkhaus E, Salnikow K. Nickel essentiality, toxicity, and carcinogenicity. Crit Rev in Oncol Hematol , 2002; 42(1), 35-56. (Pubitemid 34229147)
4. IARC. Chromium, nickel and welding. Monogr Eval Carcinog Risks Hum, 1990; 49, 1-648.
5. Andrew AS, Warren AJ, Barchowsky A, et al. Genomic and Proteomic Profiling of Responses to Toxic Metals in Human Lung Cells. Environ Health Perspect, 2003; 111(77), 825-38. (Pubitemid 36701362)
6. Jones PA, Baylin SB. The epigenomics of cancer. Cell, 2007; 128(4), 683-92. (Pubitemid 46273572)
7. Laird P W. Cancer epigenetics. Hum Mol Genet, 2005; 14(suppl 1), R65-R76. (Pubitemid 40542622)
8. Salnikow K, Zhitkovich A. Genetic and Epigenetic Mechanisms in Metal Carcinogenesis and Cocarcinogenesis: Nickel, Arsenic, and Chromium. Chem Res Toxicol, 2008; 21(1), 28-44.
9. Lee YW, Klein CB, Kargacin B, et al . Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens. Mol Cell Biol, 1995; 15(5), 2547-57.
10. Hattermann K, Mehdorn HM, Mentlein R, et al . A methylation-specific and SYBR-green-based quantitative polymerase chain reaction technique for O6-methylguanine DNA methyltransferase promoter methylation analysis. Anal Biochem , 2008; 377(1), 62-71.
11. Ohmori T, Okada K, Terada M, et al . Low susceptibility of specific inbred colonies of rats to nickel tumorigenesis in soft tissue. Cancer Lett , 1999; 136(1), 53-8. (Pubitemid 29142302)
12. Livak K J, Schmittgen T D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 2001; 25(4), 402-8. (Pubitemid 34164012)
13. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc , 2008; 3(6), 1101-8. (Pubitemid 351818697)
14. Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA, 1996; 93(18), 9821-6. (Pubitemid 26296693)
15. Costa M, Sutherland JE, Wu P. Molecular biology of nickel carcinogenesis. Molecular and Cellular Biochemistry, 2001;222(1-2), 205-11. (Pubitemid 32910337)
16. Shukla S, Mirza S, Sharma G. Detection of RASSF1A and RARbeta Hypermethylation in Serum DNA from Breast Cancer Patients. Epigenetics , 2006; 1(2), 88-93.
17. Juhlin CC, Kiss NB, Villablanca A, et al . Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours. PLoS ONE, 2010; 5(3), e9472.
18. Zhang ZM, Keiichiro Joh, Yatsuki H. Retinoic acid receptor b2 is epigenetically silenced either by DNA methylation or repressive histone modifications at the promoter in cervical cancer cells. Cancer Letters, 2007; 247(2), 318-27. (Pubitemid 46240623)
19. Fackler MJ, McVeigh M, Evron E, et al . DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma. Int J Cancer, 2003; 107(6), 970-5. (Pubitemid 37429839)
20. Virmani AK, Rathi A, Zochbauer-Muller S, et al. Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas. J Natl Cancer Inst, 2000; 92(16), 1303-7. (Pubitemid 30660589)
21. Cras A, Darsin-Bettinger D, Balitrand N, et al . Epigenetic patterns of the retinoic acid receptor b2 promoter in retinoic acid-resistant thyroid cancer cells. Oncogene, 2007; 26(27), 4018-24. (Pubitemid 46884303)
22. De-Castro AJ, Gockel-Krzikalla E, Rosl F. Retinoic Acid Receptor β Silences Human Papillomavirus-18 Oncogene Expression by Induction of de Novo Methylationand Heterochromatinization of the Viral Control Region. J Biol Chem, 2007; 282(39), 28520-29. (Pubitemid 47606007)
23. Smiraglia DJ, Smith LT, Lang JC, et al. Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC). J Med Genet , 2003; 40(1), 25-33. (Pubitemid 36115121)
24. Donninger H, Vos MD, Clark GJ. The RASSF1A tumor suppressor. J Cell Sci , 2007; 120(Pt 18), 3163-72. (Pubitemid 350018407)
25. Egger G, Liang G, Aparicio A, et al. Epigenetics in human disease and prospects for epigenetic therapy. Nature, 2004;429(6990),457-63. (Pubitemid 38715140)
26. Bovenzi V, Lê NL, Côte S, et al . DNA methylation of retinoic acid receptor beta in breast cancer and possible therapeutic role of 5-aza-2′-deoxycytidine. Anticancer Drugs, 1999; 10(5), 471-6.
27. Sirchia SM, Ferguson AT, Sironi E, et al . Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells. Oncogene, 2000; 9(12), 1556-63. (Pubitemid 30175677)
28. Widschwendter M, Berger J, Hermann M, et al . Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer. J Natl Cancer Inst , 2000; 92(10), 826-32. (Pubitemid 30368039)
29. Kruyt FA, van den Brink CE, Defize LH, et al . Transcriptional regulation of retinoic acid receptor beta in retinoic acid-sensitive and -resistant P19 embryocarcinoma cells. Mech Dev , 1991; 33(3), 171-8.
30. Sirchia SM, Ren M, Pili R, et al . Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer. Cancer Res , 2002; 62(9), 2455-61. (Pubitemid 34462717)
31. Lan FF, Wang H, Chen YC, et al . Hsa-let-7g Inhibits Proliferation of Hepatocellular carcinoma Cells by Down-regulation of c-Myc and Up-regulation of p16INK4A. In: Int J Cancer , 2010; Available via DIALOG: http://www3. interscience.wiley.com/journal/123326244/abstract?CRETRY=1&SRETRY=0 Accessed 22 Mar 2010.
32. Box AH, Demetrick DJ. Cell cycle kinase inhibitor expression and hypoxia-induced cell cycle arrest in human cancer cell lines. Carcinogenesis, 2004; 25(12), 2325-35. (Pubitemid 39625172)